Annexon マネジメント
マネジメント 基準チェック /44
Annexonの CEO はDoug Loveで、 Dec2014年に任命され、 の在任期間は 9.92年です。 の年間総報酬は$ 2.45Mで、 24.2%給与と75.8%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の0.28%を直接所有しており、その価値は$ 2.16M 。経営陣と取締役会の平均在任期間はそれぞれ2.5年と6.1年です。
主要情報
Doug Love
最高経営責任者
US$2.5m
報酬総額
CEO給与比率 | 24.2% |
CEO在任期間 | 9.9yrs |
CEOの所有権 | 0.3% |
経営陣の平均在職期間 | 2.5yrs |
取締役会の平均在任期間 | 6.1yrs |
経営陣の近況
Recent updates
We're Hopeful That Annexon (NASDAQ:ANNX) Will Use Its Cash Wisely
Sep 27Speculative "Buy" Rating On Annexon: Evaluating The Potential Of ANX005 For GBS
Aug 17Annexon: Complement Inhibition Of GBS Only The Beginning With Strong Tech In Place
Jun 04Annexon: Unforced Error Sullies Prospects
Apr 03Here's Why We're Watching Annexon's (NASDAQ:ANNX) Cash Burn Situation
Nov 10Is Annexon (NASDAQ:ANNX) In A Good Position To Deliver On Growth Plans?
Jul 25Is Annexon (NASDAQ:ANNX) In A Good Position To Deliver On Growth Plans?
Apr 11Are Investors Undervaluing Annexon, Inc. (NASDAQ:ANNX) By 25%?
Feb 14We Think Annexon (NASDAQ:ANNX) Needs To Drive Business Growth Carefully
Dec 28Annexon started as a buy at Jefferies on market potential of candidates, data catalysts
Sep 16Annexon: A First Take
Aug 21Annexon Biosciences GAAP EPS of -$0.96 misses by $0.02
Aug 08Annexon to raise $130M in stock and warrant offering
Jul 08We're Keeping An Eye On Annexon's (NASDAQ:ANNX) Cash Burn Rate
Apr 16Companies Like Annexon (NASDAQ:ANNX) Are In A Position To Invest In Growth
Jan 01Companies Like Annexon (NASDAQ:ANNX) Are In A Position To Invest In Growth
Sep 08We Think Annexon (NASDAQ:ANNX) Can Afford To Drive Business Growth
May 22We Think Annexon (NASDAQ:ANNX) Can Afford To Drive Business Growth
Feb 06Dosing underway in Annexon's Phase 2/3 study of monoclonal antibody in Guillain-Barré Syndrome
Dec 21Annexon Biosciences EPS misses by $0.43
Nov 16CEO報酬分析
日付 | 総報酬 | 給与 | 会社業績 |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -US$115m |
Mar 31 2024 | n/a | n/a | -US$121m |
Dec 31 2023 | US$2m | US$593k | -US$134m |
Sep 30 2023 | n/a | n/a | -US$141m |
Jun 30 2023 | n/a | n/a | -US$143m |
Mar 31 2023 | n/a | n/a | -US$145m |
Dec 31 2022 | US$4m | US$569k | -US$142m |
Sep 30 2022 | n/a | n/a | -US$145m |
Jun 30 2022 | n/a | n/a | -US$145m |
Mar 31 2022 | n/a | n/a | -US$140m |
Dec 31 2021 | US$8m | US$534k | -US$130m |
Sep 30 2021 | n/a | n/a | -US$116m |
Jun 30 2021 | n/a | n/a | -US$103m |
Mar 31 2021 | n/a | n/a | -US$84m |
Dec 31 2020 | US$5m | US$446k | -US$70m |
Sep 30 2020 | n/a | n/a | -US$56m |
Jun 30 2020 | n/a | n/a | -US$45m |
Mar 31 2020 | n/a | n/a | -US$42m |
Dec 31 2019 | US$3m | US$396k | -US$38m |
Sep 30 2019 | n/a | n/a | -US$34m |
Jun 30 2019 | n/a | n/a | -US$28m |
Mar 31 2019 | n/a | n/a | -US$23m |
Dec 31 2018 | US$518k | US$379k | -US$18m |
報酬と市場: Dougの 総報酬 ($USD 2.45M ) は、 US市場 ($USD 3.23M ) の同様の規模の企業の平均とほぼ同じです。
報酬と収益: Dougの報酬は、過去 1 年間の会社の業績と一致しています。
CEO(最高経営責任者
Doug Love (56 yo)
9.9yrs
在職期間
US$2,453,184
報酬
Mr. Douglas Love, Esq., J.D, also known as Doug, has been the President, Director and Chief Executive Officer of Annexon Inc. since December 2014. He has extensive business and legal leadership experience...
リーダーシップ・チーム
名称 | ポジション | 在職期間 | 報酬 | 所有権 |
---|---|---|---|---|
CEO, President & Director | 9.9yrs | US$2.45m | 0.28% $ 2.2m | |
Chief Scientific Officer & Executive VP | 1.8yrs | US$1.83m | 0.048% $ 366.4k | |
Executive VP | 3.1yrs | US$1.14m | 0.068% $ 519.6k | |
Executive VP | 5.4yrs | US$1.44m | 0.026% $ 200.4k | |
Executive VP & Chief Business Officer | 4.3yrs | US$1.40m | 0.034% $ 259.7k | |
Senior Vice President of Translational Medicine | no data | データなし | データなし | |
Executive VP & Chief Medical Officer | 1.3yrs | データなし | データなし | |
Senior VP & Head of Commercial | less than a year | データなし | データなし | |
Senior VP of Medical Affairs | less than a year | データなし | データなし |
2.5yrs
平均在職期間
59.5yo
平均年齢
経験豊富な経営陣: ANNXの経営陣は 経験豊富 であると考えられます ( 2.5年の平均在職年数)。
取締役
名称 | ポジション | 在職期間 | 報酬 | 所有権 |
---|---|---|---|---|
CEO, President & Director | 9.9yrs | US$2.45m | 0.28% $ 2.2m | |
Executive VP | less than a year | US$1.14m | 0.068% $ 519.6k | |
Independent Director | 9.9yrs | US$103.93k | 0.76% $ 5.9m | |
Independent Chairman | 7.8yrs | US$132.43k | 0.00026% $ 2.0k | |
Independent Director | 4.4yrs | US$100.93k | 0% $ 0 | |
Independent Director | 3.3yrs | US$103.43k | 0% $ 0 | |
Member of Scientific Advisory Board | no data | データなし | データなし | |
Member of Scientific Advisory Board | no data | データなし | データなし | |
Member of Scientific Advisory Board | no data | データなし | データなし | |
Member of Scientific Advisory Board | no data | データなし | データなし | |
Member of Scientific Advisory Board | no data | データなし | データなし | |
Member of Scientific Advisory Board | no data | データなし | データなし |
6.1yrs
平均在職期間
66yo
平均年齢
経験豊富なボード: ANNXの 取締役会 は 経験豊富 であると考えられます ( 6.1年の平均在任期間)。